Infection in patients with congenital immune deficiencies

Current Opinion in Infectious Diseases

Volumn 11, Issue 4, 1998, Pages 419-423

  Sewell, W A Carrock ^a   Webster, A David B ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIVIRUS AGENT; CYTOKINE; GROWTH FACTOR; IMMUNOGLOBULIN;

BACTERIAL INFECTION; EARLY DIAGNOSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOPATHOGENESIS; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MYCOSIS; REVIEW; VIRUS INFECTION;

EID: 0031873742     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199808000-00004     Document Type: Review

References (36)

1. Anonymous. Primary immunodeficiency diseases. Report of a WHO • •scientific group. Clin Exp Immunol 1997; 109 (Suppl. 1 ): 1 -28. A major review of the mechanisms, clinical features and essentials of management of all the currently recognized primary immunodeficiencies. For most single-gene disorders this classification is now established, but will probably change as more genetic defects are discovered.
2. Webster ADB. Infection in primary immunodeficiency syndromes. Curr Opin Infect Dis 1994; 7:444-449.
3. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, et al. • Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 1997; 131:47-54. The only substantial survey of the clinical and immunological features of patients with XHIM.
4. Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, et al. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked hyper-IgM. J Immunol 1997; 158:977-983.
5. Samuelson A, Borrelli S, Gustafson R, Hammerstrom L, Smith CI, Jonasson J, Lindberg AA. Characterisation of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations. Scand J Infect Dis 1995; 27:303-313.
6. Steuer A, Franz A, Furr PM, Taylor-Robinson D, Webster ADB. Hughes GRV. Common variable immunodeficiency presenting as a Mycoplasma hominis septic arthritis. J Infect 1996; 33:235-237.
7. Kornfeld SJ, Haire RN, Litman GW. Primary immunodeficiency disease presenting in midlife. JAMA 1996: 276:1953-1954.
8. Franz A, Webster ADB, Furr PM, Taylor-Robinson D. Mycoplasmal • arthritis in patients with primary immunoglobulin deficiency: clinical features and outcome in 18 patients. Br J Rheumatol 1997; 36:661-668. Mycoplasma infection is the commonest cause of chronic erosive arthritis in primary antibody deficiency; this is the largest published series of the clinical features and outcomes of this complication of antibody deficiency.
9. Babb RR. Giardiasis. Taming this pervasive parasitic infection. Postgrad Med 1995; 98:155-158.
10. Rotbart HA, Jones A, Novelli V, Blanche S, Webster ADB. Pleconaril treatment of chronic enteroviral central nervous system infections in children with agammaglobulinaemia [Abstract], Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC); 1997; p. 236.
11. Rump JA, Jahreis A, Schlesier M, Stecher S, Peter HH. A double-blind, placebo-controlled, crossover therapy study with natural human IL-2 (nhulL-2) in combination with regular intravenous gammaglobulin (IVIG) nfusions in 10 patients with common variable immunodeficiency (CVID). Clin Exp Immunol 1997; 110:167-173.
12. Zhu Q, Watanabe C, LIU T, Hollenbaugh D, Blaese RM, Kanner SB, et al. Wiskott-Aldrich syndrome/X-linked thrombocytopenia: WASP gene mutations, protein expression, and phenotype Blood 1997: 90:2680-2689.
13. Featherstone C. How does one gene cause Wiskott-Aldrich syndrome? Lancet 1996; 348:950.
14. Swift M. Genetic aspects of ataxia telangiectasia. In: Immunodeficiencies. Rosen FS, Seligmann M (editors): Switzerland: Harwood Academic Publishers; 1993pp. 243-252.
15. Athma P, Rappaport R, Swift M. Molecular genotyping shows that ataxia telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 1996; 92:130-134.
16. Wilson DI, Burn J. Scrambler S, Goodship L, DiGeorge syndrome: part of CATCH22. J Med Genet 1993; 30:852-856.
17. Platonov AE, Beloborodov VB, Pavlova Ll, Vershinia IV, Kayhty H. Vaccination of patients deficient in late complement component with tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 1995; 100:32-39.
18. Summerfield JA, Ryder S, Sumiya M, Thurz M, Gorchein A, Monteil MA, Turner MW. Mannose-binding protein gene mutations associated with unusual and severe infections in adults. Lancet 1994; 345:886-889.
19. Turner MW, Mannose-binding lectin: the pluripotent molecule of the innate immune system, Immunol Today 1996; 17:532-540.
20. Thomas HC, Foster GR1 Sumiya M, Mclntosh D, Jack DL, Turner MW, Summerfield JA. Mutation of gene of mannose-binding protein associated with chronic hepatitis B viral infection. Lancet 1996; 348:1417-1419.
21. Ezekowitz A. Mannose-binding protein and susceptibility to chronic hepatitis B infection. Lancet 1996; 348:1396-1397.
22. Mead R, Jack D, Pembrey M, Tyfield L, Turner M and the ALSPAC Study • Team. Mannose-binding lectin alleles in a prospectively recruited UK population. Lancet 1997; 349:1669-1670 This study presents proposed reference values for MBL genotype frequencies in the UK population.
23. Barbosa MDFS, Nguyen QA, Tchernev VT, Ashley JA, Detter JC. Blaydes SM, et al. Identification of the homologous beige and Chediak-Higashi syndrome genes. Nature 1996; 382:262-265.
24. The International Chronic Granulomatous Disease Study Group. A controlled trial of interferon-gamma to prevent infection in chronic granulomatous disease. N Eng J Med 1991; 324:509-516.
25. Gallin JI, Farber JM, Holland SM, Nutman TB. Interferon-gamma in the management of infectious diseases. Ann Infern Med 1995; 123:216-224.
26. Dong F. Dale DC, Bonilla MA, Freedman M, Fasth A, Neijeus HJ, et al. Mutations in the granulocyte colony-stimulating factor receptor gene in patients with severe congenital neutropenia. Leukemia 1997; 11:120-125.
27. Freedman MH. Safety of long-term administration of granulocyle colony-stimulating factor for severe chronic neutropenia. Curr Opin Hematol 1997; 4:217-224.
28. Casanova JL, Jouanguy E, Lamhamedi S, Blanche S, Fisher A. Immunological conditions of children with BCG disseminated infection. Lancet 1995; 346:581.
29. Huerlin N, Dahlqvist G, Elinder G, Hammerström L, Petrini B. Fatal outcome of disseminated Mycobacterium avium infection in childhood. A case of primary incompetent monocyte/macrophage function? Acta Paediatrics 1996; 85:1511-1513.
30. Jouanguy E, Altere F, Lamhamedi S, Revy P, Emile J-F, Newport M, et al. Interferon-γ-receptor deficiency in an infant with fatal bacille Calmette-Guérin infection. N Engl J Med 1996; 335:1956-1961.
31. Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, Levin M. A mutation in the Interferon-γ -receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996; 335:1941-1949.
32. Pierre-Audigier C, Jouanguy E, Lamhamedi S, Altare F, Rauzier J. Vincent V, et al. Fatal disseminated Mycobacterium smegmatis infection in a child with inherited interferon gamma receptor deficiency. Clin Infect Dis 1997; 24:982-984.
33. Kumararatne DS. Tuberculosis and immunodeficiency: of mice and men. Clin Exp Immunol 1997; 107:11-14. An extremely useful starting point for references to the rapidly expanding field of mycobacterial immunity.
34. Unsworth DJ, Thomas HN. Missed clues and delayed diagnosis of immunodeficiency. Lancet 1997; 349:435.
35. de Vries E, Koene HR, Vossen JM, Gratama JW, von dem Borne AE, Waaijer JL, et al. Identification of an unusual Fc gamma receptor IIIa (CD 16) on natural killer cells in a patient with recurrent infections. Blood 1996; 88:3022-3027.
36. Chapel HM. Consensus on diagnosis and management of primary antibody deficiencies. BMJ 1994; 308:581-585.